Michael L. Kranda
Directeur Général chez LifeSprout, Inc.
Profil
Michael L.
Kranda currently works at LifeSprout, Inc., as Chief Executive Officer& Director from 2021, Nura, Inc., as Director, Cumbre Pharmaceuticals, Inc., as Director, and Washington State Biotechnology Business Association, as Director.
Mr. Kranda also formerly worked at Anesiva, Inc., as President & Chief Executive Officer, Vaccinogen, Inc., as Chief Executive Officer, Oxford GlycoSciences Plc, as Chief Executive Officer in 2002, BEAT BioTherapeutics Corp., as President, Chief Executive Officer & Director, Twinstrand Biosciences, Inc., as Chief Executive Officer, Raven Biotechnologies, Inc., as Chairman, PTC Therapeutics, Inc., as Independent Director from 2013 to 2015, BiPar Sciences, Inc., as Director, Immunex Corp., as President & Chief Operating Officer from 2009 to 2013, and Cercano Management LLC, as Consultant.
Mr. Kranda received his undergraduate degree and Masters Business Admin degree from Michael G.
Foster School of Business.
Postes actifs de Michael L. Kranda
| Sociétés | Poste | Début |
|---|---|---|
Nura, Inc.
 Nura, Inc. Pharmaceuticals: MajorHealth Technology Nura, Inc. discovers and develops pharmaceutical products. It offers products for the treatment of neurodegenerative diseases such as Parkinson's & Alzheimer's diseases and behavioural disorders such as depression, anxiety, schizophrenia, obesity, and addiction. The company was founded in August 2003 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
| Washington State Biotechnology Business Association | Directeur/Membre du Conseil | 15/09/2009 |
Cumbre Pharmaceuticals, Inc.
 Cumbre Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cumbre Pharmaceuticals, Inc. discovers, develops, and markets anti-infective products for the treatment of serious and life-threatening infections, particularly caused by antibiotic resistant pathogens. Cumbre Pharmaceuticals was founded in 2001 and is headquartered in Dallas, TX | Directeur/Membre du Conseil | 15/09/2009 |
LifeSprout, Inc.
 LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Directeur Général | 18/11/2021 |
Anciens postes connus de Michael L. Kranda
| Sociétés | Poste | Fin |
|---|---|---|
| PTC THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/06/2015 |
| VACCINOGEN INC | President | - |
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Président | 01/01/2008 |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | President | 01/07/2002 |
Twinstrand Biosciences, Inc.
 Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Directeur Général | - |
Formation de Michael L. Kranda
| Michael G. Foster School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PTC THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
Cercano Management LLC /Private Equity/
 Cercano Management LLC /Private Equity/ Investment ManagersFinance Cercano Management LLC /Private Equity/ (Cercano Management) is a venture capital subsidiary of Cercano Management LLC founded in 1986 by Paul Gardner Allen. The firm is headquartered in Bellevue, Washington. | Finance |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Nura, Inc.
Nura, Inc. Pharmaceuticals: MajorHealth Technology Nura, Inc. discovers and develops pharmaceutical products. It offers products for the treatment of neurodegenerative diseases such as Parkinson's & Alzheimer's diseases and behavioural disorders such as depression, anxiety, schizophrenia, obesity, and addiction. The company was founded in August 2003 and is headquartered in Seattle, WA. | Health Technology |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Commercial Services |
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Health Technology |
BiPar Sciences, Inc.
 BiPar Sciences, Inc. Pharmaceuticals: MajorHealth Technology BiPar Sciences, Inc. develops and markets drugs for cancer patients. It offers BSI-201, a poly ADP-ribose polymerase (PARP) inhibitor for metastatic triple negative breast cancer, ovarian cancer, and other malignancies; BSI-401, a follow-on PARP inhibitor candidate for pancreatic cancer; and BSI-301, an iodothyronine program with anti-tubulin properties. The company was founded by Barry M. Sherman, Thomas F. White and Allan Basbaum in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
| Washington State Biotechnology Business Association | |
Cumbre Pharmaceuticals, Inc.
Cumbre Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cumbre Pharmaceuticals, Inc. discovers, develops, and markets anti-infective products for the treatment of serious and life-threatening infections, particularly caused by antibiotic resistant pathogens. Cumbre Pharmaceuticals was founded in 2001 and is headquartered in Dallas, TX | Health Technology |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
BEAT BioTherapeutics Corp.
 BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology BEAT BioTherapeutics Corp. develops novel therapies for heart diseases. It offers BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. The company was founded by Charles E. Murry, Buddy D. Ratner, Michael Laflamme and Michael Regnier in 2008 and is headquartered in Bellevue, WA. | Health Technology |
Vaccinogen, Inc.
 Vaccinogen, Inc. BiotechnologyHealth Technology Vaccinogen, Inc. is a biotechnology company, which engages in the development and commercialization of vaccines and immunotherapeutic products for the battle of cancer. The company was founded by Michael G. Hanna, Jr. and Andrew L. Tussing on May 2, 2007 and is headquartered in Baltimore, MD. | Health Technology |
Twinstrand Biosciences, Inc.
Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Health Technology |
LifeSprout, Inc.
LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Health Technology |
